Sodium thiosulfate during hemodialysis to reduce calcification propensity

Phase 2, open-label, single-arm trial of sodium thiosulfate in arterial calcification, sponsored by Radboud University Medical Center. Primary endpoints: Difference in pre- to post-dialysis change in T50 between non-dosed and STS-dosed sessions and Change in pre-dialysis T50 from control session to each STS-dosed session. Planned start Nov 2026; status: not yet recruiting.